Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life-threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus, or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest
Laboratory investigations have examined its interactions with growth factor signaling, nitric oxide pathways, and fibroblast activity in tissue culture and preclinical contexts
Food and Drug Administration (FDA) for any medical use
The peptides chelation of copper prevents oxidative damage while enabling controlled cellular uptake, distinguishing it from other copper delivery methods
Consult a licensed medical provider before starting any peptide or supplementation protocol